John Rountree

facebook_page
twitter_page

Last quote by John Rountree

It all emphasises the importance the new GSK executive team puts on stability and long-term performance, rather than high-risk and high-reward R&D. It does not fit as well with a view that GSK will be a magnet for developing game-changing pharmaceutical R&D innovation. Investors that are more interested in high-upside with risk can take on this unit and give it more focus and space than is currently possible under GSK.feedback
share this quote
Aug 06 2017
This page is completely dedicated to what John Rountree has to say. All of John Rountree’s quotes are organized here by date and topic. The most recent quote attributed to John Rountree came from an article called GSK's hunt for more profitable drugs may come at a cost: “It all emphasises the importance the new GSK executive team puts on stability and long-term performance, rather than high-risk and high-reward R&D. It does not fit as well with a view that GSK will be a magnet for developing game-changing pharmaceutical R&D innovation. Investors that are more interested in high-upside with risk can take on this unit and give it more focus and space than is currently possible under GSK.”.
Automatically powered by Storyzy
Take our quote verification challenge and find out !
<
>
Quote Verifier
verify-icon
Check if the quote you read on social networks is authentic
facebook_page
twitter_page
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided
 
Feedback×

Quote :

Mistake :

Comments :